JP2015213501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015213501A5 JP2015213501A5 JP2015088066A JP2015088066A JP2015213501A5 JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5 JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- individual
- functional
- acid bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/259,442 | 2014-04-23 | ||
| US14/259,442 US10967013B2 (en) | 2014-04-23 | 2014-04-23 | Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same |
| US14/690,502 | 2015-04-20 | ||
| US14/690,502 US10188684B2 (en) | 2015-04-20 | 2015-04-20 | Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015213501A JP2015213501A (ja) | 2015-12-03 |
| JP2015213501A5 true JP2015213501A5 (enExample) | 2016-01-28 |
| JP6035578B2 JP6035578B2 (ja) | 2016-11-30 |
Family
ID=53008330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015088066A Active JP6035578B2 (ja) | 2014-04-23 | 2015-04-23 | 乳酸菌、それを含む組成物及びそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2937424B1 (enExample) |
| JP (1) | JP6035578B2 (enExample) |
| CN (1) | CN105002109B (enExample) |
| ES (1) | ES2624673T3 (enExample) |
| PL (1) | PL2937424T3 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6933358B2 (ja) * | 2016-04-06 | 2021-09-08 | 東海漬物株式会社 | 美肌促進剤 |
| JP6878565B2 (ja) * | 2016-07-19 | 2021-05-26 | ベネド バイオメディカル カンパニー リミテッド | 乳酸菌による大脳基底核疾患、または、チック障害を治療または予防するための薬剤 |
| KR20180019474A (ko) * | 2016-08-16 | 2018-02-26 | 주식회사 엠디헬스케어 | 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물 |
| CN107050062A (zh) * | 2016-11-08 | 2017-08-18 | 江西益盟科技有限公司 | 治疗便秘的乳酸菌组合物及其制备方法 |
| MY199866A (en) * | 2017-01-13 | 2023-11-26 | Bened Biomedical Co Ltd | A novel lactic acid bacteria and its applications |
| KR102089836B1 (ko) * | 2017-03-15 | 2020-03-16 | (주)바이오일레븐 | 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법 |
| CN106906165B (zh) * | 2017-04-25 | 2020-07-24 | 重庆第二师范学院 | 一种植物乳杆菌及其在制备预防便秘的食品中的应用 |
| CN107267416A (zh) * | 2017-07-05 | 2017-10-20 | 重庆第二师范学院 | 植物乳杆菌ys2及其在制备预防便秘的食品中的应用 |
| WO2019119261A1 (en) * | 2017-12-19 | 2019-06-27 | Dupont Nutrition Biosciences Aps | Probiotics for cognitive and mental health |
| US20200330531A1 (en) * | 2017-12-19 | 2020-10-22 | Dupont Nutrition Biosciences Aps | Probiotics for cognitive and mental health |
| MX420836B (es) * | 2018-02-02 | 2025-02-10 | Kobiolabs Inc | Cepa lactobacillus plantarum kbl396 y uso de la misma. |
| CN111035661A (zh) * | 2018-10-15 | 2020-04-21 | 深圳市华大农业应用研究院 | 植物乳杆菌的用途 |
| TWI731279B (zh) | 2018-11-21 | 2021-06-21 | 葡萄王生技股份有限公司 | 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途 |
| ES2763350B2 (es) * | 2018-11-28 | 2020-10-13 | Consejo Superior Investigacion | Cepa de christensenella minuta y uso de la misma |
| JP2022511510A (ja) * | 2018-12-06 | 2022-01-31 | デュポン ニュートリション バイオサイエンシーズ エーピーエス | 認知的健康及び精神的健康のためのプロバイオティクス |
| CN113302280B (zh) * | 2019-01-28 | 2024-05-24 | 益福生医股份有限公司 | 保护个体运动的方法 |
| EP3918055B9 (en) * | 2019-02-01 | 2025-11-05 | Bened Biomedical Co., Ltd. | Method for preventing or treating abnormal emotion or behavior in non-human animal by lactic acid bacterium |
| WO2020157297A1 (en) * | 2019-02-01 | 2020-08-06 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Lactococcus lactis strains for the prevention and/or the treatment of visceral pain |
| KR102148707B1 (ko) * | 2019-02-22 | 2020-08-31 | 한국식품연구원 | 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이 |
| CN115052969A (zh) * | 2020-02-06 | 2022-09-13 | 李旺祚 | 用于预防或治疗雷特氏综合征的乳酸菌组合物 |
| US20230330163A1 (en) * | 2020-03-25 | 2023-10-19 | Bened Biomedical Co., Ltd. | Method for reducing behavioral abnormalities |
| CN116367847A (zh) * | 2020-10-22 | 2023-06-30 | 李旺祚 | 用于治疗芳香族l-氨基酸脱羧基酶缺乏症的乳酸菌 |
| WO2022131192A1 (ja) * | 2020-12-16 | 2022-06-23 | 株式会社明治 | 脳組織の炎症改善用組成物 |
| CN113215018A (zh) * | 2021-02-04 | 2021-08-06 | 郑州大学 | 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用 |
| CN113564084A (zh) * | 2021-08-13 | 2021-10-29 | 华东理工大学 | 植物乳杆菌x7022在预防和治疗便秘上的应用 |
| TWI810645B (zh) * | 2021-09-06 | 2023-08-01 | 景岳生物科技股份有限公司 | 乳桿菌組合物及其改善抗生素造成之焦慮症的用途 |
| KR20250095634A (ko) * | 2022-10-28 | 2025-06-26 | 시에이치알. 한센 에이/에스 | 과민성 대장 증후군 증상 해결에 사용되기 위한 락티플란티바실러스 플란타룸 |
| CN117143760B (zh) * | 2023-07-12 | 2024-09-20 | 西南大学 | 一株能促进5-htp分泌及缓解抑郁的鼠李糖乳酪杆菌ky16及其应用 |
| KR102741129B1 (ko) * | 2023-11-07 | 2024-12-11 | 농업회사법인 고려홍삼원 주식회사 | 락토바실러스 플란타룸 ckh-01 균주를 포함하는 스트레스 완화 및 수면개선용 프로바이오틱스 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5725853A (en) * | 1994-10-18 | 1998-03-10 | Pioneer Hi-Bred International, Inc. | 4 strain direct-fed microbial |
| US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| JP5400779B2 (ja) * | 2008-08-21 | 2014-01-29 | サントリーホールディングス株式会社 | セロトニントランスポーター阻害活性を有する医薬品又は飲食品 |
-
2015
- 2015-04-23 EP EP15164896.1A patent/EP2937424B1/en active Active
- 2015-04-23 PL PL15164896T patent/PL2937424T3/pl unknown
- 2015-04-23 JP JP2015088066A patent/JP6035578B2/ja active Active
- 2015-04-23 CN CN201510195767.9A patent/CN105002109B/zh active Active
- 2015-04-23 ES ES15164896.1T patent/ES2624673T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015213501A5 (enExample) | ||
| Jiang et al. | Evaluation of probiotic properties of Lactobacillus plantarum WLPL04 isolated from human breast milk | |
| Sokovic Bajic et al. | GABA-producing natural dairy isolate from artisanal zlatar cheese attenuates gut inflammation and strengthens gut epithelial barrier in vitro | |
| Álvarez-Cisneros et al. | Antibiotic resistance in lactic acid bacteria | |
| Wang et al. | Swine-derived probiotic Lactobacillus plantarum inhibits growth and adhesion of enterotoxigenic Escherichia coli and mediates host defense | |
| EP4272815A3 (en) | New medical use of probiotics | |
| Sharma et al. | Antibiotic resistance among commercially available probiotics | |
| Presti et al. | Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect | |
| Mirzaei et al. | Antimicrobial properties of lactic acid bacteria isolated from traditional yogurt and milk against Shigella strains | |
| Matsuzaki et al. | Immunomodulating activity of exopolysaccharide‐producing Leuconostoc mesenteroides strain NTM048 from green peas | |
| Zhang et al. | Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens | |
| NZ593708A (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| Helmy et al. | In vitro evaluation of the impact of the probiotic E. coli Nissle 1917 on Campylobacter jejuni’s invasion and intracellular survival in human colonic cells | |
| RU2010142003A (ru) | Синбиотическая смесь | |
| RU2016143921A (ru) | Композиция для применения в лечении или предупреждении вирусных или бактериальных инфекций у субъекта, проходящего противоопухолевую химиотерапию, лечение лейкоза или лечение СПИД, содержащая l.reuteri ler03 и/или l.salivarius ls06 | |
| Mandal et al. | Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics | |
| JP2018532034A (ja) | 機能性水和ヒアルロン酸及びこれを利用した優れた腸粘膜付着能及び選択的拮抗作用を有するコーティング乳酸菌の製造方法 | |
| Seo et al. | Development of anti-inflammatory probiotic Limosilactobacillus reuteri EFEL6901 as kimchi starter: In vitro and in vivo evidence | |
| Srinu et al. | Evaluation of different lactic acid bacterial strains for probiotic characteristics | |
| Wu et al. | Evaluation of the probiotic potential of Lactobacillus delbrueckii ssp. indicus WDS-7 isolated from Chinese traditional fermented buffalo milk in vitro | |
| RU2015103115A (ru) | Применение тиосульфата для усиления антипатогенного действия лактобацилл | |
| Yu et al. | Mucin2 is Required for Probiotic Agents-Mediated Blocking Effects on Meningitic E. coli-Induced Pathogenicities S | |
| RU2016143922A (ru) | Терапевтическое средство для применения в лечении опухолей, синдрома приобретенного иммунодефицита и лейкозов путем двойной иммунной биостимуляции | |
| Lim | Anti-Helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi | |
| Nawaz et al. | Screening and characterization of new potentially probiotic lactobacilli from breast-fed healthy babies in Pakistan |